Lineage Cell Therapeutics Inc (LCTX) Implied Volatility Current

Tracking LCTX implied volatility helps you identify when options premiums on Lineage Cell Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Lineage Cell Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when LCTX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Lineage Cell Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For LCTX, tracking metrics like LCTX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on LCTX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer.

It also offers Renevia, a facial aesthetics product. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where LCTX implied volatility sits today versus where it has been. Our scanner ranks Lineage Cell Therapeutics Inc implied volatility against its historical range, surfaces extremes in LCTX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Lineage Cell Therapeutics Inc IV is rich or cheap — measure it, then act on it.